[1]
Ingle, S.J. and Tapar, K.K. 2016. QSAR and Docking Studies on 1,2-benzisoxazole Derivatives for Antipsychotic activity against Dopamine receptor (D2). Current Research in Pharmaceutical Sciences. 6, 2 (Jul. 2016), 31-34.